AstraZeneca has made a non-binding offer of about $10 billion for Rhythm Pharmaceuticals, Reuters reports. Rhythm’s latest results show the attraction of its rare-obesity franchise, but milestone payments complicate the headline price.
Announced positive topline induction data for SPY003 from Part A of the Phase 2 SKYLINE trial (“SKYLINE”), completing proof-of-concept for all three monotherapies in inflammatory bowel disease (“IBD”). SKYLINE Part B is
PITTSBURGH, Nov. 03, 2026 (GLOBE NEWSWIRE) — Duolingo, Inc. (NASDAQ: DUOL) announced results for the third quarter ended September 30, 2026 in a shareholder letter that is posted on its Investor Relations
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) — Monte Rosa Therapeutics, Inc. (Nasdaq: GLUE), a clinical-stage biotechnology company developing novel molecular glue degrader (MGD)-based medicines, today announced the grant of inducement equity awards to four
ATLANTA, Nov. 03, 2026 (GLOBE NEWSWIRE) — Atlanticus Holdings Corporation (NASDAQ: ATLC) (“Atlanticus,” the “Company,” “we,” “our” or “us”), a financial technology company that enables its bank, retail and healthcare partners to
Creates a Full-Stack RF Front-End Platform for Next-Generation Smartphones Expands Reach Across Four Secular Growth Markets – Physical AI, Defense, Infrastructure, and Automotive Broadens Technology Portfolio with RF GaN, Low-Voltage Power and
Net Investment Income of $0.33 Per Share for Q3 2026; Declared Quarterly Distribution of $0.31 Per Share NEW YORK, Nov. 03, 2026 (GLOBE NEWSWIRE) — SLR Investment Corp. (NASDAQ: SLRC) (the “Company”,
Growing Customer Demand and Backlog; Continued Program Wins; Continued Growth in Vietnam Production SPOKANE VALLEY, Wash., Nov. 03, 2026 (GLOBE NEWSWIRE) — Key Tronic Corporation (Nasdaq: KTCC), a provider of electronic manufacturing
Third quarter net income of $1.34 per diluted shareand adjusted operating income of $1.34 per diluted share Third quarter 2026 highlights compared to third quarter 2025, unless otherwise noted:(1) Net income decreased
Third Quarter Revenue Increased 25.1% Year-over-Year Third Quarter Revenue Less Ancillary Services Increased 26.0% Year-over-Year Previous Fiscal Year 2026 FX-Neutral Revenue Less Ancillary Services growth guidance raised by 2 pts at midpoint,
DELAWARE, Ohio, Nov. 03, 2026 (GLOBE NEWSWIRE) — Greif, Inc. (NYSE: GEF, GEF.B), a world leader in industrial packaging products and services, today announced fourth quarter and fiscal 2026 results. On June
Follow